Bacterial translocation (BT) in cirrhosis

Authors

  • Reiner Wiest,

    1. Department of Internal Medicine I, University of Regensburg Hospital Franz-Josef-Strauss-Allee, Regensburg, Germany
    Search for more papers by this author
  • Guadalupe Garcia-Tsao

    Corresponding author
    1. Yale University School of Medicine, New Haven, CT
    • VA Connecticut Healthcare System and Section of Digestive Diseases, Yale University School of Medicine, 333 Cedar Street, 1080 CMP, P.O. Box 3333, New Haven, CT 06520-8019
    Search for more papers by this author

  • Conflict of interest: Nothing to report.

Abstract

Gut flora and bacterial translocation (BT) play an important role in the pathogenesis of the complications of cirrhosis. Research on the pathogenesis of BT and its clinical significance transcends established boundaries between microbiology, cell biology, intestinal pathophysiology, and immunology. This review delineates multiple mechanisms involved in the process of BT, with an emphasis on alterations in intestinal flora and mucosal barrier function, particularly immunological defense mechanisms. Current knowledge on the innate and adaptive immune response that allows a “friendly” communication between bacteria and host is summarized, and alterations occurring in cirrhosis that may facilitate BT are discussed. In addition, definition of a “pathological” BT is proposed together with an analysis of the anatomical site and route of BT. Finally, therapeutic approaches for the prevention of BT in experimental and human cirrhosis are reviewed. Future research in the field of BT in cirrhosis will allow the development of new therapeutic targets in the prevention of infections and other complications of cirrhosis. (HEPATOLOGY 2005;41:422–433.)

Ancillary